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We report the prevalence of the O139 serogroup in Calcutta, India, after its reemergence in August 1996 and
the spread of the reemerged clone to other parts of the country by using previously established molecular
markers. Phenotypically, the reemerged Vibrio cholerae O139 displayed a difference compared to those that
appeared in late 1992 and 1993 in that the current O139 strains are sensitive to co-trimoxazole. Ribotyping
with the enzyme BglI produced two rRNA restriction patterns in the O139 strains isolated after August 1996,
and these patterns were identical to those exhibited by strains of O139 isolated in 1992. Three clones of V.
cholerae O139 are currently prevailing in the country, with strains exhibiting three bands after HindIII
digestion and hybridization with a ctxA probe being dominant. The reemergence of V. cholerae O139 in Calcutta
after a 32-month quiescent period reestablishes the O139 serogroup as an entity which is likely to play a crucial
role in the temporal antigenic variations among the serogroups of V. cholerae causing cholera.
Vibrio cholerae is classified into more than 155 serogroups
based on the heat-stable somatic O antigen (21, 22). The dis-
ease cholera is, however, caused by only two serogroups,
namely, O1 and O139. The O139 serogroup is a recent addi-
tion which appeared abruptly in September 1992 in southern
India (17) and rapidly spread to virtually all areas where chol-
era is endemic in India (14) and in neighboring countries (15).
The extent and rapidity of the spread of the O139 serogroup
led us to conclude that this event was the beginning of the
eighth pandemic of cholera (14). In February 1994, the O1
serogroup, which had reappeared sporadically in July 1993,
again replaced the O139 serogroup and became the dominant
serogroup causing cholera in Calcutta, India (11). Subsequent
studies showed that the O1 serogroup which replaced the O139
serogroup was a new clone of O1 ElTor biotype (7, 19, 27).
A quiescent period followed in the brief history of V. chol-
erae O139, and it was thought that the appearance of O139 was
a one-time event. However, an upsurge of V. cholerae O139
was observed in Calcutta in August 1996 (10), and the O139
serogroup again became the dominant serogroup causing chol-
era by September 1996. Molecular studies showed that the
O139 strains which reemerged in August 1996 were indistin-
guishable from the O139 strains isolated in 1992 and 1993 by
ribotyping but showed a unique change in the structure and
organization of the CTX genetic element (20). In this study,
the prevalence of the O139 serogroup in Calcutta after its
reemergence and the spread of the reemerged clone to other
parts of the country were investigated by using previously es-
tablished molecular markers.
The present study is a part of the continuing surveillance
program of the National Institute of Cholera and Enteric Dis-
eases, Calcutta, on cholera. Stool specimens were obtained
from patients admitted to the Infectious Diseases Hospital,
Calcutta, the only hospital which admits cholera patients from
the metropolitan city and suburban areas. Methods adopted
for collection, transport, bacteriological examination of stool
samples, identification, and serotyping of V. cholerae have been
described in detail previously (11). The National Institute of
Cholera and Enteric Diseases, India’s national reference lab-
oratory for cholera, and a World Health Organization Refer-
ence Centre for Training and Research on Diarrhoeal Dis-
eases, confirms and characterizes V. cholerae strains submitted
from all over the country and from neighbouring countries.
Strains received are characterized by using a panoply of tests as
previously described (14). A total of 17 strains of V. cholerae
O139 isolated between August 1996 and July 1997 from Cal-
cutta and other parts of the country (Table 1) were included in
this study for extensive molecular characterization. Another
two strains of V. cholerae O139, one isolated in 1992 in Cal-
cutta (SG24) and the other isolated in the same year in Madras
(MO45 [ATCC 51394]), were included in this study for com-
parison.
Representative strains of V. cholerae O139 isolated from
hospitalized patients in Calcutta in 1992 and 1993 (101 strains)
and 1996 and 1997 (89 strains) and all 17 representative strains
of V. cholerae O139 included in the detailed molecular char-
acterization study were examined for resistance to ampicillin
(AP) (10 mg), chloramphenicol (30 mg), co-trimoxazole (25
mg), ciprofloxacin (5 mg), furazolidone (FZ) (100 mg), genta-
micin (10 mg), neomycin (NM) (30 mg), nalidixic acid (NA) (30
mg), norfloxacin (10 mg), streptomycin (SM) (10 mg), and tet-
racycline (30 mg) by using commercial discs (Hi Media, Bom-
bay, India) as described previously (11). Characterization of
strains as susceptible or resistant was based on size of the
inhibition zone around each disc according to the manufactur-
er’s instructions, which matched the interpretive criteria rec-
ommended by the World Health Organization (25). Strains
showing an intermediate zone of inhibition were interpreted as
resistant to that drug on the basis of previous MIC studies
conducted with V. cholerae (26).
Genomic DNA extraction and Southern hybridization were
performed as described earlier (19). Genomic DNA was di-
gested with BglI for ribotyping and with HindIII and BglII for
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CTX restriction fragment length polymorphism (RFLP) fol-
lowing the manufacturer’s instructions (Boehringer Mannheim
GmbH, Mannheim, Germany). Digested fragments were sep-
arated by agarose gel electrophoresis (0.8% gel) and Southern
hybridized on nylon membrane (Hybond-N1, Amersham Life
Science, Little Chalfont, Buckinghamshire, England). The
rRNA gene probe was a 7.5-kb BamHI fragment of pKK3535,
which is a pBR322-derived plasmid containing an Escherichia
coli rRNA operon consisting of one copy each of the genes
coding for 5S rRNA, 16S rRNA, 23S rRNA, and tRNAGlu (5).
The gene probe for cholera toxin was a 0.5-kb EcoRI fragment
of pCVD27, which is a pBR325-derived plasmid containing an
XbaI-ClaI fragment representing 94% of the gene encoding
the A subunit of cholera toxin (ctxA) cloned with EcoRI linkers
(9). Labelling of the probes, hybridization, and detection of the
bands were performed with the ECL detection system (Amer-
sham Life Science) and Kodak Biomax Film (Eastman Kodak
Co., Rochester, N.Y.).
The monthly incidence of V. cholerae O1 and O139 in pa-
tients admitted to the Infectious Diseases Hospital, Calcutta,
from January 1996 to December 1997 is shown in Fig. 1. The
resurgence of V. cholerae O139 in Calcutta began in August
1996, and by September 1996, the O139 serogroup dominated
over the O1 serogroup after a lapse of 32 months. After Sep-
tember 1996, O139 strains were also received from different
parts of the country. The O139 serogroup dominated until
September 1997. From October to December 1997, the O1
serogroup again became the dominant serogroup associated
with cholera in Calcutta.
Comparison of the drug resistance patterns between O139
strains isolated in 1992 and 1993 and those isolated in 1996 and
1997 showed that the strains from 1996 and 1997 were suscep-
FIG. 1. Monthly isolation of various serogroups of V. cholerae from patients hospitalized because of acute secretory diarrhea at the Infectious Diseases Hospital,
Calcutta, from January 1996 to December 1997 (J to D, respectively).
TABLE 1. Antibiogram and RFLP analyses of the CTX genetic element of the 17 clinical V. cholerae O139 strains isolated from different
parts of India after September 1996
Strain no. Place of isolation Region Antibiogram Restriction patterna of CTX genetic element Ribotypeb
AS258 Calcutta Eastern AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2; BglII: 23.0 3a
MD1 Midnapur Eastern AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2; BglII: 23.0 5a
MD3 Midnapur Eastern AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2; BglII: 23.0 3a
NPO549 Nagpur Deccan AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2; BglII: 23.0 3a
YO29 Yavatmal Deccan AP-FZ-SM HindIII: 14.0, 9.0, 7.2; BglII: 23.0 3a
MO585 Madras Southern AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2 3a
NPO554 Nagpur Deccan AP-FZ-SM HindIII: 14.0, 9.0, 7.2 3a
NPO564 Nagpur Deccan AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2 3a
YO30 Yavatmal Deccan AP-FZ-SM HindIII: 14.0, 9.0, 7.2 3a
SO58 Sewagram Deccan AP-FZ-SM HindIII: 14.0, 9.0, 7.2 3a
APO16 Amravati Deccan AP-FZ-NM-SM HindIII: 14.0, 9.0, 7.2 3a
VO82 Vellore Southern AP-FZ-NA-SM HindIII: 20.0; BglII: 8.2, 7.2 3a
VO83 Vellore Southern AP-FZ-NA-SM HindIII: 20.0; BglII: 8.2, 7.2 3a
PO42 Pune Western AP-FZ-NA-SM HindIII: 20.0; BglII: 8.2, 7.2 5a
WSO10 Solapur Deccan AP-FZ-NA-SM HindIII: 20.0; BglII: 8.2, 7.2 5a
BOM6 Bombay Western AP-FZ-NM-NA-SM HindIII: 15; BglII: 7.2 5a
MO579 Madras Southern AP-FZ-SM HindIII: 15 3a
a Restriction enzyme and sizes (in kilobases) of the fragments of the CTX genetic element of V. cholerae O139 which hybridized with the ctxA gene probe.
b Ribotype designations are the same as those of Popovic et al. (16).
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tible to co-trimoxazole, unlike the O139 strains from 1992 and
1993, which were resistant to this drug, corroborating our pre-
vious observation (10). Interestingly, the O139 strains isolated
in 1996 and 1997 are becoming increasingly resistant to ampi-
cillin and neomycin but increasingly susceptible to chloram-
phenicol and, to a certain extent, streptomycin. The drug re-
sistance pattern of the O139 strains isolated from different
parts of the country was similar to the drug resistance pattern
of the newly emerged O139 strains in Calcutta with the excep-
tion of five strains which were additionally resistant to nalidixic
acid (Table 1).
Ribotyping with the enzyme BglI produced two distinct
rRNA restriction patterns in the O139 strains isolated after
August 1996 which were similar to the ribotype patterns of the
O139 strains isolated in 1992 and 1993 and were designated as
3a and 5a by Popovic et al. (16). The ribotypes 3a and 5a
differed from each other by a single 6-kb band. Southern blot
analysis of HindIII-digested genomic DNA of 11 of the 17
O139 strains showed that three bands of 14, 9, and 7.2 kb
hybridized with the ctxA probe, as reported previously (20).
The strains demonstrating this pattern were widely distributed
in the country and dominated in the eastern and Deccan re-
gions in India. Two other HindIII patterns, one in which a
15-kb fragment (shown by two strains) and one in which a
20-kb fragment (shown by four strains) hybridized with the
ctxA probe, were found sporadically among strains from South-
ern and Western regions and from a single place in the Deccan
region (Table 1). The HindIII digest showing the 15-kb frag-
ment resembled the pattern shown by SG24 and MO45, the
O139 strains which appeared in 1992 (data not shown).
We further analyzed representative strains showing the
three different HindIII patterns with BglII to understand the
structure of the CTX genetic element. Strains which showed
three bands after HindIII digestion showed a single band of
about 23 kb when digested with BglII and probed with ctxA,
indicating that in these strains the BglII site resides outside the
CTX genetic element, which corroborates our earlier findings
(20). Southern blot hybridization of BglII-digested genomic
DNA by using a ctxA probe of a representative strain which
gave the 15-kb band upon HindIII digestion showed a single
fragment of 7.2 kb. This indicates the presence of a single copy
of the CTX genetic element. Southern blot hybridization of
BglII-digested genomic DNA of representative strains which
showed a 20-kb HindIII fragment with a ctxA probe demon-
strated two fragments of 7.2 and 8.2 kb. This indicates that in
these strains there is a tandem duplication of the CTX genetic
element.
Until September 1997, the O139 serogroup dominated as
the causal serogroup of cholera among hospitalized patients
admitted to the Infectious Diseases Hospital, Calcutta. As
shown previously (20), the recent O139 strains show substan-
tial reorganization in the structure of the CTX genetic element
compared to the 1992 and 1993 O139 strains. In this study, we
exploited the unusual HindIII RFLP of the CTX genetic ele-
ment of strains of the reemergent O139 serogroup to monitor
the spread of this clone to other parts of India. From the
results, it is clear that strains of O139 exhibiting three bands
after HindIII digestion of the genomic DNA and subsequently
hybridized with ctxA probe constitute the dominant O139 clone
currently prevailing in the country. This new O139 clone ap-
pears to have originated in Calcutta because the representative
strain (MO579) of O139 isolated after September 1996 in
Madras showed a single 15-kb band after HindIII digestion,
while the representative 1997 Madras strain (MO585) showed
three bands like those shown by the Calcutta O139 strains after
HindIII digestion. Therefore, it appears that the new O139
clone may have spread from Calcutta to Madras, which is in
contrast to the 1992 situation, when O139 spread from Madras
to Calcutta (14, 17).
This study also shows that O139 strains similar to a 1992
clone of O139, which showed a single band of around 15 kb
after HindIII digestion, are prevalent in certain areas, like
Bombay. Further restriction analysis with BglII revealed that
this strain had only a single copy of the CTX genetic element.
In the 1992 epidemic strains of O139, most strains had two
tandemly duplicated copies of the CTX genetic element, while
in some a single copy of the element was detected (3, 24). The
strains BOM6 and MO579, therefore, appear to be remnants
of the O139 clone from 1992 and 1993, which continue to
prevail in or represent areas where the new O139 clone has not
yet spread. A third HindIII restriction pattern among O139
strains from Vellore, Pune, and Solapur, India, was observed.
Although in these strains there was a duplication of the CTX
genetic element, as evident from BglII digestion, the HindIII
20-kb band does not resemble the 1992 O139 pattern. There-
fore, it is evident that three clones of V. cholerae O139 are
currently prevailing in the country, with strains exhibiting three
bands after HindIII digestion being dominant.
Phenotypically, the reemerged V. cholerae O139 displayed a
difference compared to those that appeared in late 1992 and
1993 in that the current O139 strains are sensitive to co-tri-
moxazole. There was an apparent correlation between antibio-
gram and HindIII restriction patterns of the CTX genetic el-
ement in the O139 strains examined in this study. The
dominant antibiogram of O139 strains displaying three bands
after HindIII digestion and hybridization with a ctxA probe was
AP-FZ-NM-SM or AP-FZ-SM, while the prominent antibio-
gram of O139 strains displaying a single 20- or 15-kb HindIII
band was AP-FZ-NA-SM (Table 1). Careful scrutiny of data
on multidrug resistance of V. cholerae over the past few years
indicates that the recent rapid changes being witnessed may be
a consequence of the rapid changes in drug resistance of V.
cholerae (12). In fact, at the time of the genesis of the O139
serogroup, two principal features which distinguished O139
from O1 ElTor strains were the novel O139 serogroup antigen
and the distinct pattern of antibiotic resistance (1, 17). While
examining the spread of the novel clone of O1 ElTor, we
recently observed that the emergence of a new clone of V.
cholerae O1 was preceded by a change in the antibiogram (2).
Although there were differences in the antibiogram and
CTX RFLP between the O139 strains isolated in 1992 and
1993 and in 1996 and 1997, the ribotypes displayed by these
temporally spaced-out O139 strains were similar to the ri-
botypes of the strains isolated in 1992 and 1993. No new ri-
botype was detected in this study. In contrast, in Bangladesh,
differences in ribotypes of O139 strains isolated between 1993
and 1996 have been reported (8, 16). Despite the geographical
proximity of and the movement of population between Cal-
cutta and Bangladesh, the epidemiology of cholera can be
quite different in the two areas and may be dependent on,
among other things, ecological conditions. An outstanding ex-
ample was the reappearance of the classical biotype of V.
cholerae in 1983 in Bangladesh (18). The classical biotype of V.
cholerae O1, however, did not spread to Calcutta or to any
other areas where cholera is endemic in India. Within Bang-
ladesh itself, there appears to be a selective distribution of
biotypes, with the classical biotype clustering in the southern
region while the ElTor biotype prevails in the other regions
(23).
The reemergence of V. cholerae O139 in Calcutta after a
32-month quiescent period reestablishes the O139 serogroup
as an entity which is likely to play a crucial role in the temporal
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antigenic variations among the cholera-causing serogroups of
V. cholerae. The periodic shift between the O1 and O139 se-
rogroups is reminiscent of the shifts from the Ogawa to the
Inaba serotypes periodically witnessed among O1 V. cholerae
in earlier years, possibly mediated by the immune pressure in
the population. For some inexplicable reason, the Inaba sero-
type of the O1 serogroup has disappeared, with the last Inaba
dominance being recorded in 1989 in Calcutta (13). The com-
plete disappearance of the Inaba serotype from Calcutta
strangely coincides with the genesis of the O139 serogroup.
Molecular studies have now shown that the O139 serogroup
originated from an O1 biotype ElTor strain by acquisition of
novel DNA which replaced the rfb genes encoding the O1
antigen (4, 6). Epidemiologically, it appears that the O139
serogroup has appeared as an alternate to the Inaba serotype
of the O1 serogroup to aid the persistence and perpetuate the
spread of cholera.
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